TSHA · Company research
Taysha Gene Therapies, Inc. Common Stock (TSHA): Stock News & Events
Recent company-linked news records available in the database.
RESEARCH CONTEXT
Understand the numbers
Recent company-linked news records available in the database. Use period, currency, units and source fields when interpreting values.
16records availableHealthcare
Stock News & Events data
Database-backed records only
| title | summary | url | source | published at | sentiment | sentiment score | relevance score |
|---|---|---|---|---|---|---|---|
| Taysha Gene Therapies (TSHA) Faces A Split Valuation Debate, Is It Really 66% Below Fair Value? - Yahoo Finance | Taysha Gene Therapies (TSHA) Faces A Split Valuation Debate, Is It Really 66% Below Fair Value? Yahoo Finance | View source ↗ | Yahoo Finance | Oct 9, 2026 | neutral | 0 | 0.6 |
| Taysha Gene Therapies (TSHA) Stock May Be Above Fair Value On Book Value - Yahoo Finance | Taysha Gene Therapies (TSHA) Stock May Be Above Fair Value On Book Value Yahoo Finance | View source ↗ | Yahoo Finance | Oct 9, 2026 | neutral | 0 | 0.6 |
| Four new hires get Taysha stock awards tied to 384,000 shares, plus rights to buy more. - Stock Titan | Four new hires get Taysha stock awards tied to 384,000 shares, plus rights to buy more. Stock Titan | View source ↗ | Stock Titan | Oct 2, 2026 | neutral | 0 | 0.6 |
| These 3 Risky Stocks Could Be Sitting on 100% Upside - MarketBeat | These 3 Risky Stocks Could Be Sitting on 100% Upside MarketBeat | View source ↗ | MarketBeat | Sep 7, 2026 | neutral | 0 | 0.6 |
| TSHA-102 Rett Data, Expanded Catalent Deal And New Financing Might Change The Case For Investing In Taysha Gene Therapies (TSHA) - Simply Wall Street | TSHA-102 Rett Data, Expanded Catalent Deal And New Financing Might Change The Case For Investing In Taysha Gene Therapies (TSHA) Simply Wall Street | View source ↗ | Simply Wall Street | Aug 20, 2026 | neutral | 0 | 0.6 |
| Taysha Gene Therapies (TSHA) Stock Retreats As Cash Burn Deepens - Simply Wall Street | Taysha Gene Therapies (TSHA) Stock Retreats As Cash Burn Deepens Simply Wall Street | View source ↗ | Simply Wall Street | Aug 13, 2026 | neutral | 0 | 0.6 |
| Taysha Gene Therapies (TSHA) Stock Trades At A Premium Despite A 232% Return - Simply Wall Street | Taysha Gene Therapies (TSHA) Stock Trades At A Premium Despite A 232% Return Simply Wall Street | View source ↗ | Simply Wall Street | Aug 13, 2026 | neutral | 0 | 0.6 |
| Taysha Sets Aug. 11 Webcast on Rare-Disease Gene Therapies - Stock Titan | Taysha Sets Aug. 11 Webcast on Rare-Disease Gene Therapies Stock Titan | View source ↗ | Stock Titan | Aug 4, 2026 | neutral | 0 | 0.6 |
| Taysha Gene Therapies president sells $1.25m in stock - Investing.com | Taysha Gene Therapies president sells $1.25m in stock Investing.com | View source ↗ | Investing.com | Jul 10, 2026 | neutral | 0 | 0.6 |
| Taysha Gene Therapies Prices $200 Million Public Offering of Common Stock and Pre-Funded Warrants - Quiver Quantitative | Taysha Gene Therapies Prices $200 Million Public Offering of Common Stock and Pre-Funded Warrants Quiver Quantitative | View source ↗ | Quiver Quantitative | Jun 25, 2026 | neutral | 0 | 0.6 |
| Taysha Gene Therapies stock tumbles on public offering pricing - Investing.com | Taysha Gene Therapies stock tumbles on public offering pricing Investing.com | View source ↗ | Investing.com | Jun 25, 2026 | neutral | 0 | 0.6 |
| Taysha Gene Therapies (TSHA) Stock Looks Undervalued After Sharp Three Year Recovery - Yahoo Finance | Taysha Gene Therapies (TSHA) Stock Looks Undervalued After Sharp Three Year Recovery Yahoo Finance | View source ↗ | Yahoo Finance | Jun 13, 2026 | neutral | 0 | 0.6 |
| Taysha Gene Therapies: Shortened Timeline Increases The Potential (NASDAQ:TSHA) - Seeking Alpha | Taysha Gene Therapies: Shortened Timeline Increases The Potential (NASDAQ:TSHA) Seeking Alpha | View source ↗ | Seeking Alpha | Jun 1, 2026 | neutral | 0 | 0.6 |
| Taysha Gene Therapies Reports First Quarter 2026 Financial Results and Provides Corporate Update - GlobeNewswire | Taysha Gene Therapies Reports First Quarter 2026 Financial Results and Provides Corporate Update GlobeNewswire | View source ↗ | GlobeNewswire | May 6, 2026 | neutral | 0 | 0.6 |
| TSHA Stock Jumps As Canaccord Hikes Price Target - StocksToTrade | TSHA Stock Jumps As Canaccord Hikes Price Target StocksToTrade | View source ↗ | StocksToTrade | Apr 19, 2026 | neutral | 0 | 0.6 |
| Taysha Gene Therapies Stock Soars After FDA Grants Breakthrough Therapy Designation To Gene Therapy - Stocktwits | Taysha Gene Therapies Stock Soars After FDA Grants Breakthrough Therapy Designation To Gene Therapy Stocktwits | View source ↗ | Stocktwits | Mar 5, 2026 | neutral | 0 | 0.6 |
Informational research only, not financial advice. Forecasts are uncertain and can be wrong.